AssetMark Inc
PVLA icon

AssetMark Inc’s Palvella Therapeutics PVLA Stock Holding History

AssetMark Inc’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$138 Buy
+1
New +$148 ﹤0.01% 3664

Other funds holding PVLA

Clio Asset Management
Clio Asset Management Charlottesville, Virginia $119M AUM 1.1% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
iA Global Asset Management
iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return
Oak Ridge Investments
Oak Ridge Investments Chicago, Illinois $1.68B AUM 48.52% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Aspiriant LLC
Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return

AssetMark Inc's PVLA Position: Q3 2026 in Review

AssetMark Inc opened a new position in Palvella Therapeutics (PVLA) in Q3 2026: 1 share worth $138. The stake represents ﹤0.01% of the portfolio and ranks #3664 among its holdings.

43 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • AssetMark Inc held 1 share of Palvella Therapeutics worth $138 as of Q3 2026.
  • Palvella Therapeutics was a new AssetMark Inc position in Q3 2026.
  • Palvella Therapeutics made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3664 holding.
  • 43 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.